Found 5 matching trials
A Dose-Finding Study of Birabresib (MK-8628), a Small Molecule Inhibitor of the Bromodomain and Extra-Terminal (BET) Proteins, in Adults With Selected Advanced Solid Tumors (MK-8628-003) PHASE1 Open-label, phase I, non-randomized, multicentric study of single-agent bir...
Show More Location
Multiple Locations
Learn More & Join Trial
A Dose-finding Study of the Bromodomain (Brd) Inhibitor OTX015/ Birabresib (MK-8628) in Hematologic Malignancies (MK-8628-001) PHASE1 The primary purpose of this study was to determine the recommended dose (RD...
Show More Location
Multiple Locations
Learn More & Join Trial
A Dose Exploration Study With Birabresib (MK-8628) in Participants With Selected Advanced Solid Tumors (MK-8628-006) PHASE1 This is a study to determine the recommended dose of birabresib (MK-8628)(f...
Show More Location
Multiple Locations
Learn More & Join Trial
A Dose Exploration Study With Birabresib (MK-8628) in Participants With Selected Hematologic Malignancies (MK-8628-005) PHASE1 This is a study to determine the recommended dose of birabresib (MK-8628) f...
Show More Location
Multiple Locations
Learn More & Join Trial
A Dose-finding Study of Birabresib (MK-8628) in Participants With Recurrent Glioblastoma Multiforme (MK-8628-002) PHASE2 A study of single-agent birabresib (MK-8628) (formerly known as OTX015) in ...
Show More Location
Multiple Locations
Learn More & Join Trial